A Simple Score to Identify Super-Responders to Sacubitril/Valsartan in Ambulatory Patients With Heart Failure

INTRODUCTION: Sacubitril/valsartan (SV) promotes cardiac remodeling and improves prognosis in patients with heart failure (HF). However, the response to the drug may vary between patients and its implementation in daily clinical practice has been slower than expected. Our objective was to develop a...

Descripción completa

Detalles Bibliográficos
Autores principales: Moliner-Abós, Carles, Mojón Álvarez, Diana, Rivas-Lasarte, Mercedes, Belarte, Laia Carla, Pamies Besora, Julia, Solé-González, Eduard, Fluvià-Brugues, Paula, Zegrí-Reiriz, Isabel, López López, Laura, Brossa, Vicens, Pirla, Maria José, Mesado, Nuria, Mirabet, Sonia, Roig, Eulàlia, Álvarez-García, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930570/
https://www.ncbi.nlm.nih.gov/pubmed/33679455
http://dx.doi.org/10.3389/fphys.2021.642117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930570/
https://www.ncbi.nlm.nih.gov/pubmed/33679455
http://dx.doi.org/10.3389/fphys.2021.642117

Ejemplares similares